| NCT03405376 |
Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03405376 |
Recruiting |
Yeungnam University College of Medicine |
2019-03-31 |
| NCT03417401 |
Surgical Stabilizer Assisted RVC With rtPA for CRVO |
https://ClinicalTrials.gov/show/NCT03417401 |
Completed |
Universitaire Ziekenhuizen Leuven |
2017-04-13 |
| NCT03223714 |
Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03223714 |
Recruiting |
Chengdu Kanghong Biotech Co., Ltd. |
2019-12-31 |
| NCT03108352 |
Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03108352 |
Recruiting |
Chengdu Kanghong Biotech Co., Ltd. |
2019-12-31 |
| NCT03093701 |
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT03093701 |
Active, not recruiting |
Taiwan Liposome Company |
2020-12-31 |
| NCT03056092 |
Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab |
https://ClinicalTrials.gov/show/NCT03056092 |
Recruiting |
St. Michael’s Hospital, Toronto |
2020-02-28 |
| NCT03056079 |
Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept |
https://ClinicalTrials.gov/show/NCT03056079 |
Recruiting |
St. Michael’s Hospital, Toronto |
2020-02-28 |
| NCT03038048 |
30g vs 33g Needle for Intravitreal Injections |
https://ClinicalTrials.gov/show/NCT03038048 |
Completed |
Wills Eye |
2017-04-27 |
| NCT02953938 |
Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety |
https://ClinicalTrials.gov/show/NCT02953938 |
Completed |
Novartis |
2018-12-28 |
| NCT02898480 |
Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning |
https://ClinicalTrials.gov/show/NCT02898480 |
Completed |
University of Aarhus |
2016-11-14 |
| NCT02867735 |
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema |
https://ClinicalTrials.gov/show/NCT02867735 |
Completed |
Novartis |
2018-02-15 |
| NCT02747030 |
Phase I RVC With Ocriplasmin for CRVO |
https://ClinicalTrials.gov/show/NCT02747030 |
Completed |
Universitaire Ziekenhuizen Leuven |
2017-08-10 |
| NCT02698566 |
A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS) |
https://ClinicalTrials.gov/show/NCT02698566 |
Completed |
Genentech, Inc. |
2016-04-05 |
| NCT02614937 |
Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT02614937 |
Completed |
Ohr Pharmaceutical Inc. |
2014-12-31 |
| NCT02800642 |
Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO |
https://ClinicalTrials.gov/show/NCT02800642 |
Completed |
Bayer |
2019-07-31 |
| NCT02571972 |
Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. |
https://ClinicalTrials.gov/show/NCT02571972 |
Completed |
Wills Eye |
2015-09-30 |
| NCT02556723 |
Intravitreal Injections of Ziv-aflibercept for Macular Diseases |
https://ClinicalTrials.gov/show/NCT02556723 |
Completed |
Retina Clinic, Sao Paulo, Brazil |
2015-09-30 |
| NCT02033031 |
Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT02033031 |
Completed |
Medical University of Vienna |
2012-11-30 |
| NCT02521116 |
Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap |
https://ClinicalTrials.gov/show/NCT02521116 |
Completed |
Medical University of Vienna |
2017-01-03 |
| NCT02510885 |
SD-OCT Angiography |
https://ClinicalTrials.gov/show/NCT02510885 |
Recruiting |
Duke University |
2020-05-31 |
| NCT02503540 |
Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO |
https://ClinicalTrials.gov/show/NCT02503540 |
Completed |
The Cleveland Clinic |
2018-02-06 |
| NCT02478515 |
Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT02478515 |
Completed |
Nagoya City University |
2019-03-31 |
| NCT02387788 |
Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO |
https://ClinicalTrials.gov/show/NCT02387788 |
Completed |
Aerpio Therapeutics |
2017-04-30 |
| NCT02303184 |
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO |
https://ClinicalTrials.gov/show/NCT02303184 |
Completed |
Clearside Biomedical, Inc. |
2016-03-31 |
| NCT02245516 |
Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema |
https://ClinicalTrials.gov/show/NCT02245516 |
Completed |
Kala Pharmaceuticals, Inc. |
2014-12-31 |
| NCT02144662 |
Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT02144662 |
Completed |
St. Marianna University School of Medicine |
2017-01-31 |
| NCT02140411 |
Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. |
https://ClinicalTrials.gov/show/NCT02140411 |
Completed |
Novartis |
2016-12-21 |
| NCT02118831 |
Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF |
https://ClinicalTrials.gov/show/NCT02118831 |
Completed |
California Retina Consultants |
2014-02-28 |
| NCT01295112 |
Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01295112 |
Completed |
Texas Retina Associates |
2015-10-31 |
| NCT01277302 |
A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01277302 |
Completed |
Genentech, Inc. |
2012-10-31 |
| NCT02006147 |
Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO |
https://ClinicalTrials.gov/show/NCT02006147 |
Active, not recruiting |
Taiwan Liposome Company |
2020-12-31 |
| NCT01976338 |
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) |
https://ClinicalTrials.gov/show/NCT01976338 |
Completed |
Novartis |
2016-03-28 |
| NCT01976312 |
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT01976312 |
Completed |
Novartis |
2016-03-14 |
| NCT01975103 |
Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases |
https://ClinicalTrials.gov/show/NCT01975103 |
Recruiting |
Federal University of Rio Grande do Sul |
2020-04-30 |
| NCT01969708 |
Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) |
https://ClinicalTrials.gov/show/NCT01969708 |
Active, not recruiting |
The Emmes Company, LLC |
2016-11-30 |
| NCT01903720 |
A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01903720 |
Completed |
Allergan |
2014-09-24 |
| NCT01870427 |
NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions |
https://ClinicalTrials.gov/show/NCT01870427 |
Completed |
Northern California Retina Vitreous Associates |
2015-08-31 |
| NCT01790685 |
Ozurdex for Retinal Vein Occlusion Study (ORVO Study) |
https://ClinicalTrials.gov/show/NCT01790685 |
Completed |
Johns Hopkins University |
2014-12-31 |
| NCT01789437 |
Diameters and Wall-to-lumen Ratio of Retinal Arterioles in Patients With Retinal Vein Occlusion. |
https://ClinicalTrials.gov/show/NCT01789437 |
Completed |
Università degli Studi di Brescia |
2012-06-30 |
| NCT01767545 |
Dexamethasone-implant for the Treatment of RVO |
https://ClinicalTrials.gov/show/NCT01767545 |
Completed |
Ludwig-Maximilians - University of Munich |
2011-01-31 |
| NCT01746615 |
Assessment of Retinal Vessel Diameters and Red Blood Velocities in Patients With BRVO and Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01746615 |
Recruiting |
Medical University of Vienna |
2020-01-31 |
| NCT01724554 |
Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion |
https://ClinicalTrials.gov/show/NCT01724554 |
Completed |
Ophthalmic Consultants of Boston |
2014-10-31 |
| NCT01710839 |
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01710839 |
Completed |
Greater Houston Retina Research |
2015-10-31 |
| NCT01662518 |
DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT01662518 |
Completed |
Centro de Pesquisa Rubens Siqueira |
2016-01-31 |
| NCT01640171 |
Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival |
https://ClinicalTrials.gov/show/NCT01640171 |
Completed |
Retina Vitreous Associates of Florida |
2013-09-30 |
| NCT01614509 |
Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01614509 |
Completed |
Yeungnam University College of Medicine |
2012-08-31 |
| NCT01599650 |
Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01599650 |
Completed |
Novartis |
2015-05-31 |
| NCT01581411 |
Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01581411 |
Completed |
Weill Medical College of Cornell University |
2015-11-30 |
| NCT01580020 |
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO |
https://ClinicalTrials.gov/show/NCT01580020 |
Completed |
Novartis |
2014-10-31 |
| NCT01535261 |
Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01535261 |
Completed |
Novartis |
2015-03-31 |
| NCT01521559 |
Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO) |
https://ClinicalTrials.gov/show/NCT01521559 |
Completed |
Regeneron Pharmaceuticals |
2013-08-31 |
| NCT01512901 |
Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI) |
https://ClinicalTrials.gov/show/NCT01512901 |
Completed |
Santen Pharmaceutical Co., Ltd. |
NA |
| NCT01471691 |
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab |
https://ClinicalTrials.gov/show/NCT01471691 |
Completed |
Hanscom, Thomas, M.D. |
2014-02-28 |
| NCT01468844 |
Minocycline to Treat Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01468844 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-02-01 |
| NCT01468831 |
Minocycline to Treat Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01468831 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-02-20 |
| NCT01449682 |
Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections. |
https://ClinicalTrials.gov/show/NCT01449682 |
Completed |
Retina Macula Institute |
2012-07-31 |
| NCT01448018 |
Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01448018 |
Completed |
Centre Hospitalier Intercommunal Creteil |
2013-06-30 |
| NCT01442064 |
An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) |
https://ClinicalTrials.gov/show/NCT01442064 |
Completed |
Genentech, Inc. |
2010-07-31 |
| NCT01428388 |
Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01428388 |
Completed |
Barnes Retina Institute |
2015-10-31 |
| NCT01427751 |
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01427751 |
Completed |
Allergan |
2014-11-04 |
| NCT01396083 |
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT01396083 |
Completed |
Novartis |
2014-01-31 |
| NCT01396057 |
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) |
https://ClinicalTrials.gov/show/NCT01396057 |
Completed |
Novartis |
2013-06-30 |
| NCT01377597 |
Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01377597 |
Completed |
Novartis |
2012-04-30 |
| NCT04290195 |
Use of Ziv Aflibercept in Different Retinal Diseases |
https://ClinicalTrials.gov/show/NCT04290195 |
Completed |
Tanta University |
2019-12-01 |
| NCT04142164 |
Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections |
https://ClinicalTrials.gov/show/NCT04142164 |
Recruiting |
Vienna Institute for Research in Ocular Surgery |
2021-01-01 |
| NCT04120636 |
Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole |
https://ClinicalTrials.gov/show/NCT04120636 |
Recruiting |
Targeted Therapy Technologies, LLC |
2020-10-30 |
| NCT04120311 |
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole |
https://ClinicalTrials.gov/show/NCT04120311 |
Recruiting |
Targeted Therapy Technologies, LLC |
2020-08-25 |
| NCT04085341 |
A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT04085341 |
Active, not recruiting |
Graybug Vision |
2020-04-30 |
| NCT03981549 |
Treatment of Central Retinal Vein Occlusion Using Stem Cells Study |
https://ClinicalTrials.gov/show/NCT03981549 |
Recruiting |
The Emmes Company, LLC |
2022-12-31 |
| NCT03918590 |
Post Intravitreal Injection Topical NSAID vs. Patching |
https://ClinicalTrials.gov/show/NCT03918590 |
Enrolling by invitation |
The New York Eye & Ear Infirmary |
2019-05-01 |
| NCT03908307 |
Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China |
https://ClinicalTrials.gov/show/NCT03908307 |
Recruiting |
Allergan |
2021-09-30 |
| NCT03892434 |
Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO |
https://ClinicalTrials.gov/show/NCT03892434 |
Recruiting |
Yeungnam University College of Medicine |
2019-12-18 |
| NCT03802630 |
Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT03802630 |
Recruiting |
Novartis |
2023-05-26 |
| NCT03739593 |
Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT03739593 |
Active, not recruiting |
Aerie Pharmaceuticals |
2020-05-31 |
| NCT03680794 |
Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies |
https://ClinicalTrials.gov/show/NCT03680794 |
Recruiting |
CHU de Reims |
2021-12-01 |
| NCT03651011 |
Navigated Laser In Branch Retinal Vein Occlusion Study |
https://ClinicalTrials.gov/show/NCT03651011 |
Recruiting |
Odense University Hospital |
2020-08-10 |
| NCT03525132 |
Study of the Retinal Vascularization by Laser Doppler Velocimetry Coupled With an Adaptive Optics Camera ( AO-LDV) |
https://ClinicalTrials.gov/show/NCT03525132 |
Recruiting |
University Hospital, Grenoble |
2020-03-18 |
| NCT01247220 |
REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study |
https://ClinicalTrials.gov/show/NCT01247220 |
Completed |
Retina Associates of Florida, P.A. |
2014-05-31 |
| NCT01231633 |
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT01231633 |
Completed |
Long Island Vitreoretinal Consultants |
2014-09-30 |
| NCT01198327 |
Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01198327 |
Completed |
Johns Hopkins University |
2012-12-31 |
| NCT01085734 |
Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01085734 |
Completed |
Maturi, Raj K., M.D., P.C. |
2011-10-31 |
| NCT01053858 |
Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision |
https://ClinicalTrials.gov/show/NCT01053858 |
Completed |
Hallym University Medical Center |
2009-01-31 |
| NCT01028248 |
Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01028248 |
Completed |
California Retina Consultants |
2012-06-30 |
| NCT01027650 |
Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT01027650 |
Completed |
Allergan |
2012-04-30 |
| NCT01027481 |
Ranibizumab in Patients With Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT01027481 |
Completed |
Medical University of Vienna |
2009-11-30 |
| NCT01012973 |
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT01012973 |
Completed |
Bayer |
2011-02-28 |
| NCT01003106 |
Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions |
https://ClinicalTrials.gov/show/NCT01003106 |
Completed |
Johns Hopkins University |
2015-04-30 |
| NCT00970957 |
Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00970957 |
Completed |
Instituto Universitario de OftalmobiologÃa Aplicada (Institute of Applied Ophthalmobiology) - IOBA |
2013-02-28 |
| NCT00952614 |
A Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00952614 |
Completed |
Duke University |
2009-05-31 |
| NCT00943072 |
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT00943072 |
Completed |
Regeneron Pharmaceuticals |
2010-10-31 |
| NCT00942864 |
Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT00942864 |
Completed |
Novartis |
2009-12-31 |
| NCT00906685 |
Bevacizumab for Central Retinal Vein Occlusion Study |
https://ClinicalTrials.gov/show/NCT00906685 |
Completed |
St. Erik Eye Hospital |
2011-03-31 |
| NCT00831350 |
Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations |
https://ClinicalTrials.gov/show/NCT00831350 |
Completed |
Barnes Retina Institute |
2011-07-31 |
| NCT01968239 |
Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT |
https://ClinicalTrials.gov/show/NCT01968239 |
Completed |
University of Leipzig |
2016-06-17 |
| NCT00805064 |
Combined Triple Procedure in Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT00805064 |
Completed |
Johann Wolfgang Goethe University Hospital |
2007-12-31 |
| NCT00804102 |
Transcorneal Electrical Stimulation Therapy for Retinal Disease |
https://ClinicalTrials.gov/show/NCT00804102 |
Completed |
Okuvision GmbH |
2011-04-30 |
| NCT02486484 |
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection |
https://ClinicalTrials.gov/show/NCT02486484 |
Recruiting |
Rafic Hariri University Hospital |
2019-05-31 |
| NCT03790852 |
Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO |
https://ClinicalTrials.gov/show/NCT03790852 |
Active, not recruiting |
Kodiak Sciences Inc |
2021-06-30 |
| NCT02390245 |
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study |
https://ClinicalTrials.gov/show/NCT02390245 |
Active, not recruiting |
Wills Eye |
2019-09-30 |
| NCT01573572 |
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium |
https://ClinicalTrials.gov/show/NCT01573572 |
Completed |
Bausch Health Americas, Inc. |
2019-11-04 |
| NCT00636493 |
Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO) |
https://ClinicalTrials.gov/show/NCT00636493 |
Completed |
Duke University |
2009-05-31 |
| NCT00612261 |
Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00612261 |
Completed |
Yonsei University |
2007-08-31 |
| NCT00567697 |
A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO |
https://ClinicalTrials.gov/show/NCT00567697 |
Completed |
Aleris Helse |
2008-10-31 |
| NCT00562406 |
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) |
https://ClinicalTrials.gov/show/NCT00562406 |
Completed |
Klinikum Ludwigshafen |
2010-09-30 |
| NCT00532142 |
The ROVO Study: Radial Optic Neurotomy for CVO |
https://ClinicalTrials.gov/show/NCT00532142 |
Completed |
Rudolf Foundation Clinic |
NA |
| NCT00493064 |
To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions |
https://ClinicalTrials.gov/show/NCT00493064 |
Completed |
Palo Alto Medical Foundation |
2016-10-31 |
| NCT00486018 |
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) |
https://ClinicalTrials.gov/show/NCT00486018 |
Completed |
Genentech, Inc. |
2009-05-31 |
| NCT00485836 |
A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) |
https://ClinicalTrials.gov/show/NCT00485836 |
Completed |
Genentech, Inc. |
2009-06-30 |
| NCT00407355 |
Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions |
https://ClinicalTrials.gov/show/NCT00407355 |
Completed |
Johns Hopkins University |
2013-02-28 |
| NCT00406796 |
Lucentis for Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT00406796 |
Completed |
California Retina Consultants |
2008-09-30 |
| NCT00406471 |
Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00406471 |
Completed |
Greater Houston Retina Research |
2011-01-31 |
| NCT00406107 |
Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00406107 |
Completed |
Palmetto Retina Center, LLC |
2007-12-31 |
| NCT00403039 |
Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema |
https://ClinicalTrials.gov/show/NCT00403039 |
Completed |
Vitreous -Retina- Macula Consultants of New York |
2011-12-31 |
| NCT00370266 |
Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00370266 |
Completed |
Shahid Beheshti University of Medical Sciences |
2007-10-31 |
| NCT00308477 |
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00308477 |
Completed |
Sanwa Kagaku Kenkyusho Co., Ltd. |
NA |
| NCT00168324 |
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00168324 |
Completed |
Allergan |
2008-03-01 |
| NCT00168298 |
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion |
https://ClinicalTrials.gov/show/NCT00168298 |
Completed |
Allergan |
2008-03-01 |
| NCT00106132 |
Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage |
https://ClinicalTrials.gov/show/NCT00106132 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00105027 |
The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study |
https://ClinicalTrials.gov/show/NCT00105027 |
Completed |
The Emmes Company, LLC |
2009-02-28 |
| NCT00101764 |
Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders |
https://ClinicalTrials.gov/show/NCT00101764 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00088283 |
Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) |
https://ClinicalTrials.gov/show/NCT00088283 |
Completed |
Eyetech Pharmaceuticals |
NA |
| NCT00071227 |
Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders |
https://ClinicalTrials.gov/show/NCT00071227 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00035906 |
Research Study in Patients With Persistent Macular Edema |
https://ClinicalTrials.gov/show/NCT00035906 |
Completed |
Allergan |
2004-08-31 |
| NCT00000131 |
Central Vein Occlusion Study (CVOS) |
https://ClinicalTrials.gov/show/NCT00000131 |
Completed |
National Eye Institute (NEI) |
NA |